Bb Biotech as of June 30, 2015
Portfolio Holdings for Bb Biotech
Bb Biotech holds 29 positions in its portfolio as reported in the June 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 11.2 | $413M | 3.6M | 115.73 | |
| Incyte Corporation (INCY) | 10.6 | $390M | 3.7M | 104.21 | |
| ISIS Pharmaceuticals | 9.2 | $341M | 5.9M | 57.55 | |
| Gilead Sciences (GILD) | 8.6 | $318M | 2.7M | 117.08 | |
| Radius Health | 7.2 | $266M | 3.9M | 67.70 | |
| Agios Pharmaceuticals (AGIO) | 6.0 | $221M | 2.0M | 111.14 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.5 | $165M | 1.3M | 123.48 | |
| Neurocrine Biosciences (NBIX) | 4.2 | $154M | 3.2M | 47.76 | |
| Medivation | 4.0 | $147M | 1.3M | 114.20 | |
| Alexion Pharmaceuticals | 3.8 | $141M | 777k | 180.77 | |
| Halozyme Therapeutics (HALO) | 3.7 | $137M | 6.1M | 22.58 | |
| Receptos | 3.4 | $126M | 665k | 190.05 | |
| Alnylam Pharmaceuticals (ALNY) | 3.1 | $116M | 966k | 119.87 | |
| Regeneron Pharmaceuticals (REGN) | 2.7 | $101M | 198k | 510.13 | |
| Novavax | 2.5 | $91M | 8.2M | 11.14 | |
| Tetraphase Pharmaceuticals | 1.9 | $72M | 1.5M | 47.44 | |
| Alder Biopharmaceuticals | 1.7 | $61M | 1.2M | 52.97 | |
| Cempra | 1.6 | $61M | 1.8M | 34.36 | |
| Puma Biotechnology (PBYI) | 1.6 | $61M | 522k | 116.75 | |
| Ptc Therapeutics I (PTCT) | 1.6 | $60M | 1.3M | 48.13 | |
| Clovis Oncology | 1.5 | $54M | 618k | 87.88 | |
| Tesaro | 1.4 | $53M | 905k | 58.79 | |
| Intercept Pharmaceuticals In | 1.2 | $44M | 181k | 241.38 | |
| Infinity Pharmaceuticals (INFIQ) | 0.8 | $30M | 2.7M | 10.95 | |
| Juno Therapeutics | 0.7 | $24M | 450k | 53.33 | |
| Kite Pharma | 0.6 | $21M | 350k | 60.97 | |
| Achillion Pharmaceuticals | 0.3 | $11M | 1.3M | 8.86 | |
| Theravance | 0.2 | $6.0M | 332k | 18.07 | |
| Theravance Biopharma (TBPH) | 0.1 | $4.7M | 359k | 13.02 |
